Moleculin Biotech Inc (MBRX)
4.72
+0.41
(+9.56%)
USD |
NASDAQ |
Apr 26, 16:00
4.72
0.00 (0.00%)
After-Hours: 20:00
Moleculin Biotech Price to Book Value: 0.4033 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 0.3681 |
| April 24, 2024 | 0.3716 |
| April 23, 2024 | 0.393 |
| April 22, 2024 | 0.3674 |
| April 19, 2024 | 0.3973 |
| April 18, 2024 | 0.3865 |
| April 17, 2024 | 0.3657 |
| April 16, 2024 | 0.3657 |
| April 15, 2024 | 0.381 |
| April 12, 2024 | 0.3953 |
| April 11, 2024 | 0.4075 |
| April 10, 2024 | 0.4443 |
| April 09, 2024 | 0.4468 |
| April 08, 2024 | 0.4314 |
| April 05, 2024 | 0.4443 |
| April 04, 2024 | 0.4528 |
| April 03, 2024 | 0.4485 |
| April 02, 2024 | 0.4656 |
| April 01, 2024 | 0.4844 |
| March 28, 2024 | 0.5049 |
| March 27, 2024 | 0.4733 |
| March 26, 2024 | 0.3998 |
| March 25, 2024 | 0.4485 |
| March 22, 2024 | 0.4874 |
| March 21, 2024 | 0.5664 |
| Date | Value |
|---|---|
| March 20, 2024 | 0.539 |
| March 19, 2024 | 0.6712 |
| March 18, 2024 | 0.7048 |
| March 15, 2024 | 0.6337 |
| March 14, 2024 | 0.6864 |
| March 13, 2024 | 0.7182 |
| March 12, 2024 | 0.719 |
| March 11, 2024 | 0.8099 |
| March 08, 2024 | 0.8639 |
| March 07, 2024 | 0.8586 |
| March 06, 2024 | 0.8586 |
| March 05, 2024 | 0.8637 |
| March 04, 2024 | 0.8817 |
| March 01, 2024 | 0.783 |
| February 29, 2024 | 0.8061 |
| February 28, 2024 | 0.7816 |
| February 27, 2024 | 0.7894 |
| February 26, 2024 | 0.7548 |
| February 23, 2024 | 0.6918 |
| February 22, 2024 | 0.66 |
| February 21, 2024 | 0.6423 |
| February 20, 2024 | 0.6405 |
| February 16, 2024 | 0.6375 |
| February 15, 2024 | 0.6407 |
| February 14, 2024 | 0.6533 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2828
Minimum
Sep 20 2023
8.801
Maximum
Feb 10 2021
1.747
Average
0.9439
Median
Aug 16 2021
Price to Book Value Benchmarks
| Merck & Co Inc | 8.841 |
| Lixte Biotechnology Holdings Inc | 14.91 |
| Moderna Inc | 2.979 |
| NovaBay Pharmaceuticals Inc | 1.723 |
| Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
| Price | 4.72 |
| Earnings Yield | -324.1% |
| Market Cap | 10.51M |